Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on June 10, 2026

3 hours ago

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Indeterminate GlobeNewswire

4 hours ago

Senior Dog Joint Supplements: What Veterinarians Look For

Indeterminate GlobeNewswire

4 hours ago

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Indeterminate GlobeNewswire

4 hours ago

Ligand Announces 2026 Investor Day in New York City

Indeterminate GlobeNewswire

4 hours ago

Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease

Indeterminate GlobeNewswire

4 hours ago

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

Indeterminate GlobeNewswire

4 hours ago

Fresh From the U.S., BrewDog Unleashes Iconic American Craft Beers Across the U.K.

Indeterminate GlobeNewswire

4 hours ago

BMGL to Effect Reverse Share Split on June 22, 2026

Indeterminate GlobeNewswire

4 hours ago

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

Indeterminate GlobeNewswire

4 hours ago

Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany

Indeterminate GlobeNewswire

5 hours ago

DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting

Indeterminate GlobeNewswire

6 hours ago

Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment

Indeterminate GlobeNewswire

6 hours ago

Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne

Indeterminate GlobeNewswire

6 hours ago

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

Indeterminate GlobeNewswire

7 hours ago

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Indeterminate GlobeNewswire

8 hours ago

Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director

Indeterminate GlobeNewswire

8 hours ago

Imprivata, leader nelle soluzioni di gestione degli accessi, entra nel mercato italiano per supportare le organizzazioni sanitarie a migliorare la sicurezza senza rallentare la produttività

Indeterminate GlobeNewswire

8 hours ago

Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

Indeterminate GlobeNewswire

9 hours ago

Vara receives CE mark for tomosynthesis AI - extending Europe’s leading screening-grade AI portfolio to 3D

Indeterminate GlobeNewswire

10 hours ago

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Indeterminate GlobeNewswire